 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
[This information is provided from the Bill Tracking & Text Search system for 
the following unprinted amendment:]  
 
Amendment Name: Amendment CA (S -452) (LD 2106 2020)  
Date: 7/27/2020

Page 1 - 129LR2690(02)-1
COMMITTEE AMENDMENT1L.D. 2106
2
3HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES
4Reproduced and distributed under the direction of the Secretary of the Senate.
5STATE OF MAINE
6SENATE
7129TH LEGISLATURE
8SECOND SPECIAL SESSION
9COMMITTEE AMENDMENT “      ” to S.P. 752, L.D. 2106, Bill, “An Act 
10Regarding Prior Authorizations for Prescription Drugs”
11Amend the bill by striking out everything after the enacting clause and inserting the 
12following:
13'Sec. 1.  24-A MRSA §4304, sub-§2, as amended by PL 2019, c. 273, §1, is 
14further amended to read:
152.  Prior authorization of nonemergency services.  Except for a request in exigent 
16circumstances as described in section 4311, subsection 1-A, paragraph B, a request by a 
17provider for prior authorization of a nonemergency service must be answered by a carrier 
18within 72 hours or 2 business days, whichever is less, in accordance with this subsection.
19A.  Both the provider and the enrollee on whose behalf the authorization was 
20requested must be notified by the carrier of its determination.
21B.  If the carrier responds to a request by a provider for prior authorization with a 
22request for additional information, the carrier shall make a decision within 72 hours 
23or 2 business days, whichever is less, after receiving the requested information.
24C.  If the carrier responds that outside consultation is necessary before making a 
25decision, the carrier shall make a decision within 72 hours or 2 business days, 
26whichever is less, from the time of the carrier's initial response.
27D.  The prior authorization standards used by a carrier must be clear and readily 
28available to enrollees, participating providers, pharmacists and other providers.  With 
29regard to prior authorization for prescription drugs, a carrier shall comply with the 
30requirements set forth in subsection 2-B.  A provider must make best efforts to 
31provide all information necessary to evaluate a request, and the carrier must make 
32best efforts to limit requests for additional information.
33If a carrier does not grant or deny a request for prior authorization within the time frames 
34required under this subsection, the request for prior authorization by the provider is 
35granted.Date: (Filing No. S-          )
COMMITTEE AMENDMENT “      ” to S.P. 752, L.D. 2106
Page 2 - 129LR2690(02)-1
COMMITTEE AMENDMENT1Sec. 2.  24-A MRSA §4304, sub-§2-B, as enacted by PL 2019, c. 273, §2, is 
2amended to read:
32-B.  Electronic transmission of prior authorization requests.  Beginning no later 
4than January 1, 2020, if a health plan provides coverage for prescription drugs, the carrier 
5must accept and respond to prior authorization requests in accordance with subsection 2 
6and this subsection through a secure electronic transmission using standards 
7recommended by a national institute for the development of fair standards and adopted by 
8a national council for prescription drug programs for electronic prescribing transactions.  
9For the purposes of this subsection, transmission of a facsimile through a proprietary 
10payer portal or by use of an electronic form is not considered electronic transmission.  A 
11carrier's electronic transmission system for prior authorization requests for prescription 
12drugs must comply with the following.
13A.  No later than January 1, 2022, unless a waiver is granted by the superintendent, a 
14carrier or entity under contract to a carrier shall make available to a provider in real 
15time at the point of prescribing one or more electronic benefit tools that are capable 
16of integrating with at least one electronic prescribing system or electronic medical 
17record system to provide complete, accurate, timely, clinically appropriate formulary 
18and benefit information specific to an enrollee, including, but not limited to, enrollee 
19cost-sharing information, information on any available formulary alternatives that are 
20clinically appropriate and information about the formulary status and the utilization 
21review and prior authorization requirements of each drug presented.  Upon a carrier's 
22request, the superintendent may grant a waiver from the requirements of this 
23paragraph based on a demonstration of good cause.
24Sec. 3.  Bureau of Insurance to monitor compliance.  Beginning January 1, 
252021, the Department of Professional and Financial Regulation, Bureau of Insurance shall 
26monitor compliance by carriers authorized to do business in this State with the 
27requirements of the Maine Revised Statutes, Title 24-A, section 4304, subsection 2-B 
28using its authority under Title 24-A, section 221.  The bureau shall also request 
29information from carriers on the adoption and usage of electronic transmission by health 
30care providers for requesting prior authorization for prescription drugs from carriers.  No 
31later than June 1, 2022, the bureau shall submit a report to the joint standing committee of 
32the Legislature having jurisdiction over health coverage and insurance matters on the 
33status of compliance by carriers.  If the bureau determines that a carrier is not complying 
34with the requirements of Title 24-A, section 4304, subsection 2-B, the bureau shall take 
35enforcement action against the carrier as appropriate.  The joint standing committee of the 
36Legislature having jurisdiction over health coverage and insurance matters may report out 
37a bill to the First Regular Session of the 131st Legislature based on the report.' 
38Amend the bill by relettering or renumbering any nonconsecutive Part letter or 
39section number to read consecutively.
40SUMMARY
41This amendment replaces the bill and makes the following changes.
421.  It requires carriers to provide by January 1, 2022 at least one electronic tool to 
43facilitate the availability of certain prescription drug benefit information in real time at 
COMMITTEE AMENDMENT “      ” to S.P. 752, L.D. 2106
Page 3 - 129LR2690(02)-1
COMMITTEE AMENDMENT1the point of prescribing and when submitting prior authorization requests for prescription 
2drugs. It also permits the Superintendent of Insurance to grant a waiver from the 
3requirements for good cause.
42.  It requires the Department of Professional and Financial Regulation, Bureau of 
5Insurance to monitor compliance by carriers with the requirements of law related to 
6electronic transmission of prior authorization requests for prescription drugs and to 
7submit a report to the joint standing committee of the Legislature having jurisdiction over 
8health coverage and insurance matters on the status of that compliance by June 1, 2022.
9FISCAL NOTE REQUIRED
10(See attached)
Approved: 04/03/20
LD 21 06 LR 2690 (02)
Fiscal Detail and NotesMinor cost increase - Ot her Special Revenue Funds
Any additional costs to the Department of Professional and Financial Regulation,  Bureau of Insurance, to monitor 
compliance as required in this bill are expected to be mi nor and can be absorbed within existing budgeted resources.129th MAINE LEGISLATURE
An Act Regarding Prior Authorizations for Prescription Drugs
Fiscal Note for Bill as Amended b y Committee Amendment " "
Committee: Health Covera ge, Insurance and Financial Services
Fiscal Note Re quired: Yes
Fiscal Note
LR2690(02) - Fiscal Note - Page 1 of 1
